Analyst Ratings for Krystal Biotech (KRYS)
KRYS Rating Summary
KRYS Price Target Summary
- Highest: $371.00 (Jefferies)
- Lowest: $216.00 (Chardan)
- Average: $309.50
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$309.50 (+22%)
* Over Last 12-Mos
Rating Score: 10 / 10
Percentile Rank: 95%
Avg. $ Target:
$309.50 (+22%)
* Over Last 12-Mos
Rating Score: 10 / 10
Percentile Rank: 95%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 1/6/2026 | Citi » Updated 1/9/2026 |
Yigal Nochomovitz | Upgrade | Buy (Neutral) |
320.00 (309.00) |
244.71 (253.69) |
3.67% | Details |
| 7/1/2025 | Clear Street » Updated 1/26/2026 |
Bill Maughan | New Coverage | Buy (N/A) |
338.00 (288.00) |
138.88 (253.69) |
82.67% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
